Pages that link to "Q43653505"
Jump to navigation
Jump to search
The following pages link to Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy (Q43653505):
Displaying 50 items.
- Hepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case report (Q24793365) (← links)
- Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort (Q24814420) (← links)
- Field evaluation of a prototype paper-based point-of-care fingerstick transaminase test (Q28533930) (← links)
- Adverse Events in a Cohort of HIV Infected Pregnant and Non-Pregnant Women Treated with Nevirapine versus Non-Nevirapine Antiretroviral Medication (Q28749406) (← links)
- Challenges in the treatment of HIV and HCV coinfection (Q30389282) (← links)
- Nevirapine-associated early hepatotoxicity: incidence, risk factors, and associated mortality in a primary care ART programme in South Africa (Q33533366) (← links)
- Hepatitis C Virus Treatment in HIV-Coinfected Patients: No Longer Different From Monoinfection Treatment (Q33576161) (← links)
- Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART (Q34070485) (← links)
- Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria (Q34174009) (← links)
- Clinicopathological correlates in HIV seropositive tuberculosis cases presenting with jaundice after initiating antiretroviral therapy with a structured review of the literature (Q34444338) (← links)
- Incidence and predictors of regimen-modification from first-line antiretroviral therapy in Thailand: a cohort study (Q34484483) (← links)
- Antiretroviral drug toxicity -- a challenge for the hepatologist? (Q34519467) (← links)
- Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients (Q34631679) (← links)
- Liver transplantation in HCV/HIV positive patients (Q34640985) (← links)
- Evaluating the utility of early laboratory monitoring of antiretroviral-induced haematological and hepatic toxicity in HIV-infected persons in Cameroon. (Q34670487) (← links)
- Nevirapine induced Stevens-Johnson syndrome in an HIV infected patient (Q34706519) (← links)
- Improvement of the study, analysis, and reporting of adverse events associated with antiretroviral therapy (Q34735212) (← links)
- Management of hepatitis C in human immunodeficiency virus-infected patients (Q34753756) (← links)
- HCV chronic hepatitis in patients with HIV: clinical management issues (Q34756205) (← links)
- Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy. (Q34785683) (← links)
- Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV. (Q34789841) (← links)
- Proteomic analysis of serum and urine of HIV-monoinfected and HIV/HCV-coinfected patients undergoing long term treatment with nevirapine. (Q34794696) (← links)
- Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting. (Q34973371) (← links)
- Looking beyond highly active antiretroviral therapy: drug-related hepatotoxicity in patients with human immunodeficiency virus infection (Q34998102) (← links)
- HIV viral suppression in the era of antiretroviral therapy (Q35059337) (← links)
- Canadian consensus guidelines for the care of HIV-positive pregnant women: putting recommendations into practice. (Q35099547) (← links)
- Pharmacoepidemiology of antiretroviral drugs in a teaching hospital in Lagos, Nigeria (Q35104583) (← links)
- Hepatitis C in the HIV-infected patient (Q35105717) (← links)
- Early versus delayed antiretroviral therapy in patients with HIV infection : a review of the current guidelines from an immunological perspective (Q35162307) (← links)
- HIV, Hepatitis B, and Hepatitis C in Zambia (Q35183973) (← links)
- Antiretroviral-associated liver injury (Q35184579) (← links)
- Toxicity of antiretroviral therapy and implications for drug development (Q35194751) (← links)
- Managing Antiretroviral-Associated Liver Disease (Q35561358) (← links)
- Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations. (Q35627943) (← links)
- Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. (Q35635844) (← links)
- HIV and HCV coinfection in haemophilia (Q35666754) (← links)
- Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors (Q35676417) (← links)
- Management of hepatitis B in patients coinfected with the human immunodeficiency virus. (Q35757754) (← links)
- HIV and hepatitis C virus co-infection (Q35818512) (← links)
- A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy (Q35827891) (← links)
- Clinical utility of current NNRTIs and perspectives of new agents in this class under development (Q35842270) (← links)
- Nevirapine in the treatment of HIV. (Q35917412) (← links)
- Hepatotoxicity of antiretrovirals: incidence, mechanisms and management (Q36008539) (← links)
- Therapies for HIV and viral hepatitis coinfection (Q36066218) (← links)
- Hepatotoxicity and nelfinavir: a meta-analysis (Q36119804) (← links)
- Liver enzymes elevation after HAART in HIV-HCV co-infection (Q36177726) (← links)
- The role of the immune system in nevirapine-induced subclinical liver injury of a rat model (Q36200176) (← links)
- Drug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy (Q36235489) (← links)
- Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials (Q36276597) (← links)
- Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan (Q36286145) (← links)